Role of 3T multiparametric magnetic resonance imaging without endorectal coil in the detection of local recurrent prostate cancer after radical prostatectomy: the radiation oncology point of view

References

• Murphy M, Berkman DS, Desai M, Benson MC, McKiernan JM, Badani KK. The number of negative pelvic lymph nodes removed does not affect the risk of biochemical failure after radical prostatectomy. BJU Int 2010;105:176–9.
   PubMed Web of Science ®Google Scholar
• Bianco FJJr, Scardino PT, Eastham JA. Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function (“trifecta”). Urology 2005;66:83–94.
   PubMed Web of Science ®Google Scholar
• Freedland SJ, Presti JCAmling CL, Kane CJ, Aronson WJ, Dorey F, et al. SEARCH Database Study Group. Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database. Urology 2003;61:736–41.
   PubMed Web of Science ®Google Scholar
• Mottet N, Bastian PJ, Bellmunt van den Bergh RC, Bolla M, van Casteren NJ, et al. Guidelines on prostate cancer. European Association of Urology 2014. Available from http://www.uroweb.org.
   Google Scholar
• Valicenti RK, Thompson IJr, Albertsen P, Davis BJ, Goldenberg SL, Wolf JS, et al. Adjuvant and salvage radiation therapy after prostatectomy: american society for radiation oncology/american urological association guidelines. Int J Radiat Oncol Biol Phys 2013;86:822–8.
   PubMed Web of Science ®Google Scholar
• Mohler JL, Kantoff PW, Armstrong AJ, Bahnson RR, Cohen M, D’Amico AV, et al. Prostate cancer, version 1.2014. J Natl Compr Canc Netw 2013;11:1471–9.
   PubMed Web of Science ®Google Scholar
• Ohri N, Dicker AP, Trabulsi EJ, Showalter TN. Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? a systematic review and regression meta-analysis with radiobiological modelling. Eur J Cancer 2012;48:837–44.
   PubMed Web of Science ®Google Scholar
• Pfister D, Bolla M, Briganti A, Carroll P, Cozzarini C, Joniau S, et al. Early salvage radiotherapy following radical prostatectomy. Eur Urol 2014;65:1034–43.
   PubMed Web of Science ®Google Scholar
• Kane CJ, Amling CL, Johnstone PA, Pak N, Lance RS, Thrasher JB, et al. Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy. Urology 2003;61:607–11.
   PubMed Web of Science ®Google Scholar
• Castellucci P, Ceci F, Graziani T, Schiavina R, Brunocilla E, Mazzarotto R, et al. Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-choline PET/CT scan before salvage radiation therapy? J Nucl Med 2014;55:1424–9.
   PubMed Web of Science ®Google Scholar
• Wu LM, Xu JR, Gu HY, Hua J, Zhu J, Chen J, et al. Role of magnetic resonance imaging in the detection of local prostate cancer recurrence after external beam radiotherapy and radical prostatectomy. Clin Oncol 2013;25:252–4.
   Web of Science ®Google Scholar
• Barchetti F, Panebianco V. Multiparametric MRI for recurrent prostate cancer post radical prostatectomy and postradiation therapy. Biomed Res Int 2014;2014:316272.
   Google Scholar
• Alfarone A, Panebianco V, Schillaci O, Salciccia S, Cattarino S, Mariotti G, et al. Comparative analysis of multiparametric magnetic resonance and PET-CT in the management of local recurrence after radical prostatectomy for prostate cancer. Crit Rev Oncol Hematol 2012;84:109–21.
   PubMed Web of Science ®Google Scholar
• Panebianco V, Barchetti F, Sciarra A, Daniela M, Forte V, Gentile V, et al. Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging. Eur Radiol 2013;23:1745–52.
   PubMed Web of Science ®Google Scholar
• Liauw SL, Pitroda SP, Eggener SE, Stadler WM, Pelizzari CA, Vannier MW, et al. Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2013;85:378–84.
   PubMed Web of Science ®Google Scholar
• Cirillo S, Petracchini M, Scotti L, Gallo T, Macera A, Bona MC, et al. Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging. Eur Radiol 2009;19:761–9.
   PubMed Web of Science ®Google Scholar
• Panebianco V, Sciarra A, Lisi D, Galati F, Buonocore V, Catalano C, et al. Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP). Eur J Radiol 2012;81:700–8.
   PubMed Web of Science ®Google Scholar
• Roy C, Foudi F, Charton J, Jung M, Lang H, Saussine C, et al. Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy. AJR Am J Roentgenol 2013;200:W361–8.
   PubMed Web of Science ®Google Scholar
• Rischke HC, Schäfer AO, Nestle U, Volegova-Neher N, Henne K, Benz MR, et al. Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil. Radiat Oncol 2012;7:185.
   PubMed Web of Science ®Google Scholar
• Verma V, Chen L, Michalski JM, Hu Y, Zhang W, Robinson K, et al. Evaluation of 3 T pelvic MRI imaging in prostate cancer patients receiving post-prostatectomy IMRT. World J Urol 2015;33:69–75.
   PubMed Web of Science ®Google Scholar
• Linder BJ, Kawashima A, Woodrum DA, Tollefson MK, Karnes J, Davis BJ, et al. Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging. Can J Urol 2014;21:7283–9.
   PubMed Web of Science ®Google Scholar
• Vees H, Buchegger F, Albrecht S, Khan H, Husarik D, Zaidi H, et al. 18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (< 1 ng/mL) after radical prostatectomy. BJU Int 2007;99:1415–20.
   PubMed Web of Science ®Google Scholar
• Panebianco V, Giove F, Barchetti F, Podo F, Passariello R. High-field PET/MRI and MRS: potential clinical and research applications. Clin Transl Imaging 2013;1:17–29.
   Google Scholar
• Zilli T, Jorcano S, Peguret N, Caparrotti F, Hidalgo A, Khan HG, et al. Dose-adapted salvage radiotherapy after radical prostatectomy based on an erMRI target definition model: toxicity analysis. Acta Oncol 2014;53:96–102.
   PubMed Web of Science ®Google Scholar
• Sefrova J, Odrazka K, Paluska P, Belobradek Z, Brodak M, Dolezel M, et al. Magnetic resonance imaging in postprostatectomy radiotherapy planning. Int J Radiat Oncol Biol Phys 2012;82:911–18.
   PubMed Web of Science ®Google Scholar
• Kupelian PA, Elshaikh M, Reddy CA, Zippe C, Klein EA. Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy. J Clin Oncol 2002;20:3376–85.
   PubMed Web of Science ®Google Scholar